Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/046994external-prioritypatent/WO2012021469A1/en
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of TN2013000045A1publicationCriticalpatent/TN2013000045A1/en
The present invention provides anti-N3pGlu Aâ antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the anti-N3pGlu Aâ antibodies or antigen-binding fragment thereof for the treatment of Alzheimers disease.
TNP2013000045A2011-08-092013-02-01Anti-n3pglu amyloid beta peptide antibodies and uses thereof
TN2013000045A1
(en)